ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
November 22, 2022 09:00 ET
|
ResMed Inc.
- Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market - Outpatient therapy services added to ResMed’s growing SaaS offering portfolio - Purchase price of €958.6 million...
ResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Support Growth, Development, and Production of Digital Health Solutions
November 16, 2022 18:30 ET
|
ResMed Inc.
New 270,000-square-foot (25,000-square-meter) facility in Tuas marks the next stage in ResMed’s more than decade-long presence in Singapore; will account for nearly 1,000 jobs across a variety of...
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
October 27, 2022 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operating profit up 4% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
October 13, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday,...
ResMed Announces Participation in the Bank of America Global Healthcare Conference
September 07, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global...
ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference
September 06, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20th Annual...
Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports
September 04, 2022 08:00 ET
|
ResMed Inc.
New prevalence figure 22–126% higher than previous estimatesPrevalence expected to reach 592 million by 2050Researchers urge global action on smoking cessation and air pollution reduction ...
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022
August 11, 2022 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 4%, operating profit up 6%, non-GAAP operating profit up 4%Quarterly dividend increases 5% to $0.44 per share Note: A webcast of ResMed’s conference call will be...
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
August 02, 2022 05:00 ET
|
ResMed Inc.
Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care...
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
July 14, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on...